Showing 361 - 380 results of 31,064 for search '(( 100 ((nn decrease) OR (we decrease)) ) OR ( 50 ((n decrease) OR (a decrease)) ))', query time: 1.01s Refine Results
  1. 361
  2. 362

    The estrogen receptor-α agonist PPT decreases cardiac myofilament activation. by Justyna Kulpa (313372)

    Published 2013
    “…Untreated controls showed no differences at any time, and are combined as a single group in each graph (N = 23). Maximum actomyosin MgATPase activity tended to decrease following PPT treatment, but did not reach statistical significance. …”
  3. 363
  4. 364
  5. 365
  6. 366

    Summary of the gradual disappearance of the peaks with decreasing DMSO-d6 concentrations. by Swagata Chakraborty (188090)

    Published 2012
    “…<p>(<b>A</b>) <sup>1</sup>H-<sup>15</sup>N HSQC spectra of GED in 100%, 90%, 85%, 80%, 70% and 50% DMSO-d6 at 45°C, as marked in the left hand panel within the spectra. …”
  7. 367
  8. 368

    Loss of Trib2 decreases disease latency of Notch-driven T-ALL. by Sarah J. Stein (3168600)

    Published 2016
    “…Mice with a body condition score of ≤2 and decreased mobility were euthanized (n = 8 Trib2<sup>+/+</sup> and n = 12 Trib2<sup>-/-</sup> recipients. …”
  9. 369
  10. 370
  11. 371
  12. 372
  13. 373
  14. 374
  15. 375
  16. 376
  17. 377
  18. 378
  19. 379
  20. 380

    Loss of Fmrp leads to decreased neuronal differentiation but increased astrocyte differentiation. by Yuping Luo (147790)

    Published 2010
    “…(E,F), Luciferase reporter assay showing that differentiating <i>Fmr1</i> KO aNPCs had decreased <i>NeuroD1</i> (E; n = 4, p<0.01), but increased GFAP (F, n = 3, p<0.05) promoter activities compared with WT aNPCs. …”